Innovex is the only commercialization resource that has the capability to provide both sales and health management services for customers' products. By combining these services, Innovex can help facilitate optimal coordination of commercialization activities that are dedicated to a single therapeutic area.

Clinical educators represent the foundation of Innovex's Health Management Services (HMS), a commercial offering first developed by Innovex in the United Kingdom and introduced in the United States in 1996.

HMS provides customers with clinical educators who work with physicians and their staff to help them understand and manage diseases, implement treatment protocols and educate their patients. These services may help patients increase their understanding of their disease, and at the same time, help physicians optimize patient outcomes and improve compliance.

Innovex Specialty Sales provides customer companies with experienced representatives who have expertise in specific therapeutic areas to maximize detailing opportunities with physicians. Coordination between HMS and specialty sales forces helps ensure that physicians understand the latest clinical guidelines for disease and that they receive the information they need to make informed prescribing decisions.

John Beriont, vice president, Health Management Services, Innovex said, "Our customers appreciate how our clinical educators create opportunities to improve patient outcomes and overall control and management of disease while helping provide access for their sales representatives."

Richard Johnson, M.D., chief executive officer, Quintiles Commercialization North America said, "We expect the demand for these services to continue to grow. In the last five years, the demand for specialty sales representatives in the U.S. has more than tripled. We estimate the market opportunity for these services across the U.S. pharmaceutical industry to be over $500 million. This agreement is yet another example of Innovex building on its broad array of commercialization services to deliver customized business solutions tailored to the specific needs of our customers." Under the terms of this agreement, Innovex Specialty Sales is responsible for all promotional activity for this product, while the HMS staff is charged solely with providing education services.

About Innovex
Innovex, a unit of Quintiles Transnational Corp. (Nasdaq: QTRN), is the world's leading commercial solutions provider and offers sales and marketing services designed to accelerate the success of pharmaceutical, biotech and medical device products. Since 1996, Innovex has created more than 94 contract sales forces in the United States, with 12,500 representatives who have launched more than 100 established products and 37 new products. For more information, visit http://www.innovex.com

Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Headquartered near Research Triangle Park, North Carolina, Quintiles is a member of the S&P 500 and Fortune 1000. For more information visit the company's Web site at www.quintiles.com. <

Information in this press release contains 'forward looking statements' regarding Quintiles and Innovex that involve risks and uncertainties that could cause actual results to differ materially, including without limitation, the risk that the market for our products and services will not grow as we expect, our ability to efficiently distribute backlog among therapeutic business units and match demand to resources, actual operating performance, the ability to maintain large client contracts or to enter into new contracts, changes in trends in the pharmaceutical industry, and the ability to operate successfully in new lines of business. Additional factors that could cause actual results to differ materially are discussed in Quintiles' recent filings with the Securities and Exchange Commission, including but not limited to its Annual Report on Form 10-K, its Form 8-Ks, and its other periodic reports, including Form 10-Qs.